IP Library Assignment 061297/0856
Patent Assignment
Reel/Frame 061297/0856

Change of Address

Recorded: 2022-08-22 Pages: 4
Assignor
INTERCEPT PHARMACEUTICALS, INC.
Executed: 2022-08-18
Assignee
INTERCEPT PHARMACEUTICALS, INC.
305 MADISON AVENUE, MORRISTOWN, NEW JERSEY, 07960
Covered Properties (18)
Treatment of fibrosis using FXR ligands
Patent: 9,498,484 →
Application: 11/081,002 →
Publication: US 2006/0069070
Steroids as Agonists for Fxr
Patent: 7,786,102 →
Application: 11/602,307 →
Publication: US 2007/0142340
Bile Acid Derivatives as Fxr Ligands for the Prevention or Treatment of Fxr-Mediated Diseases or Conditions
Patent: 7,932,244 →
Application: 11/819,517 →
Publication: US 2008/0182832
Process for Preparing 3A(Beta)-7A(Beta)-Dihydroxy-6A(Beta)-Alkyl-5BETA-Cholanic Acid
Patent: 7,994,352 →
Application: 11/914,559 →
Publication: US 2008/0214515
Bile Acid Derivatives as Fxr Ligands for the Prevention or Treatment of Fxr-Mediated Diseases or Conditions
Patent: 7,858,608 →
Application: 12/435,063 →
Publication: US 2010/0063018
23-Substituted Bile Acids as TGR5 Modulators and Methods of Use Thereof
Patent: 8,410,083 →
Application: 12/523,670 →
Publication: US 2011/0003782
TGR5 Modulators and Methods of Use Therof
Patent: 8,114,862 →
Application: 12/622,123 →
Publication: US 2010/0152151
TGR5 Modulators And Methods Of Use Thereof
Patent: 8,796,249 →
Application: 13/056,797 →
Publication: US 2011/0172198
Bile Acid Derivatives As FXR Ligands For The Prevention Or Treatment Of FXR-Mediated Diseases Or Conditions
Patent: 8,546,365 →
Application: 13/082,261 →
Publication: US 2012/0283234
TGR5 Modulators and Methods of Use Thereof
Patent: 8,999,964 →
Application: 13/129,947 →
Publication: US 2011/0263555
TGR5 Modulators and Methods of Use Thereof
Patent: 8,445,472 →
Application: 13/313,689 →
Publication: US 2012/0115832
Steroids as Agonists for Fxr
Patent: 8,969,330 →
Application: 13/761,889 →
Publication: US 2014/0024631
TGR5 Modulators and Methods of Use Thereof
Patent: 9,243,027 →
Application: 13/854,579 →
Publication: US 2014/0094443
TGR5 Modulators and Methods of Use Thereof
Patent: 9,650,409 →
Application: 13/871,492 →
Publication: US 2014/0100209
Bile Acid Derivatives as FXR Ligands for the Prevention or Treatment of FXR-Mediated Diseases or Conditions
Patent: 9,090,652 →
Application: 14/012,401 →
Publication: US 2014/0057886
Treatment of Pulmonary Disease
Application: 14/090,815 →
Publication: US 2014/0148428
TGR5 Modulators and Methods of Use Thereof
Patent: 9,540,414 →
Application: 14/449,995 →
Publication: US 2016/0052956
Treatment of Pulmonary Disease
Application: 61/730,749 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 8, 2005
From: FIORUCCI, STEFANO; PELLICCIARI, ROBERTO; PRUZANSKI, MARK
To: INTERCEPT PHARMACEUTICALS INC.
Reel/Frame 017107/0589 →
Assignment of Assignor's Interest Nov 20, 2007
From: FERRARI, MASSIMO; PELLICCIARI, ROBERTO
To: ERREGIERRE S.P.A.
Reel/Frame 020136/0481 →
Assignment of Assignor's Interest Oct 20, 2009
From: ERREGIERRE S.P.A.
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 023397/0038 →
Assignment of Assignor's Interest Feb 4, 2010
From: PELLICCIARI, ROBERTO
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 023899/0797 →
Assignment of Assignor's Interest Mar 29, 2010
From: PELLICCIARI, ROBERTO
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 024153/0831 →
Assignment of Assignor's Interest May 10, 2010
From: PELLICCIARI, ROBERTO
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 024357/0612 →
Sponsored Research Agreement Sep 30, 2010
From: FIORUCCI, STEFANO
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 025070/0367 →
Assignment of Assignor's Interest Sep 30, 2010
From: PELLICCIARI, ROBERTO; PRUZANSKI, MARK
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 025071/0006 →
Sponsored Research Agreement Sep 30, 2010
From: FIORUCCI, STEFANO
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 025086/0523 →
Assignment of Assignor's Interest Sep 30, 2010
From: PELLICCIARI, ROBERTO; PRUZANSKI, MARK
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 025072/0095 →
Change of Address of Assignee Oct 13, 2010
From: INTERCEPT PHARMACEUTICALS, INC.
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 025130/0816 →
Change of Address of Assignee Oct 13, 2010
From: INTERCEPT PHARMACEUTICALS, INC.
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 025130/0799 →
Assignment of Assignor's Interest Oct 27, 2010
From: ERREGIERRE SPA
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 025202/0921 →
Amended and Restated Sponsored Research Agreement Jan 14, 2011
From: FIORUCCI, STEFANO
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 025635/0952 →
Change of Address of Assignee Jan 21, 2011
From: INTERCEPT PHARMACEUTICALS, INC.
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 025672/0866 →
Change of Address of Assignee Jan 31, 2011
From: INTERCEPT PHARMACEUTICALS, INC.
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 025721/0419 →
Assignment of Assignor's Interest Mar 24, 2011
From: PELLICCIARI, ROBERTO
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 026011/0898 →
Assignment of Assignor's Interest Jul 18, 2011
From: PELLICCIARI, ROBERTO
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 026606/0691 →
Assignment of Assignor's Interest Jan 4, 2013
From: PELLICCIARI, ROBERTO
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 029567/0594 →
Assignment of Assignor's Interest Mar 11, 2013
From: PELLICCIARI, ROBERTO
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 029962/0282 →
Change of Name Jun 4, 2013
From: INTERCEPT PHARMACEUTICALS, INC.
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 030555/0115 →
Amended and Restated Sponsored Research Agreement Jun 4, 2013
From: FIORUCCI, STEFANO
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 030555/0093 →
Sponsored Research Agreement Jun 4, 2013
From: FIORUCCI, STEFANO
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 030555/0065 →
Assignment of Assignor's Interest Jun 4, 2013
From: PELLICCIARI, ROBERTO; PRUZANSKI, MARK
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 030542/0373 →
Assignment of Assignor's Interest Jun 7, 2013
From: PELLICCIARI, ROBERTO
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 030567/0257 →